Keyphrases
Solid Phase
100%
Murine Tumors
100%
Tumor-infiltrating Lymphocytes
100%
Anti-CD3 Antibody
100%
Recombinant interleukin-2
87%
Anti-CD3
37%
No Significant Difference
12%
Monoclonal Antibody
12%
Lymphocyte Cell
12%
Natural Killer
12%
Lysis
12%
Colon Adenocarcinoma
12%
Therapeutic Effect
12%
Tumor Regression
12%
Suboptimal Dose
12%
Sarcoma
12%
Adoptive Transfer
12%
Tumoricidal Activity
12%
Culture Conditions
12%
Micrometastatic Disease
12%
In Vitro Cytotoxicity
12%
In Vivo Antitumor Activity
12%
Cell Yield
12%
Lymphocyte Culture
12%
Autologous Tumors
12%
Sensitive Lines
12%
Immunology and Microbiology
Solid
100%
CD3 Antibody
100%
Tumor-Infiltrating Lymphocytes
100%
Recombinant Interleukin 2
87%
CD3 Antigen
50%
Antineoplastic Activity
25%
Monoclonal Antibody
12%
Colon
12%
Cytotoxicity
12%
Lymphocyte
12%